Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports and stock price the company's current number of shares outstanding is 514,000,000. At the end of 2025 the company had 514,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.